Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial.
Gao P, Wang T, Wang D, Liebeskind DS, Shi H, Li T, Zhao Z, Cai Y, Wu W, He W, Yu J, Zheng B, Wang H, Wu Y, Dmytriw AA, Krings T, Derdeyn CP, Jiao L; CASSISS Trial Investigators.
JAMA. 2022 Aug 9;328(6):534-542. doi: 10.1001/jama.2022.12000.
Percutaneous Transluminal Angioplasty with Stent Placement versus Best Medical Therapy Alone in Symptomatic Intracranial Arterial Stenosis: A Best Evidence Review.
Padalia A, Sambursky JA, Skinner C, Moureiden M.
Cureus. 2018 Jul 16;10(7):e2988. doi: 10.7759/cureus.2988.
Japanese Postmarket Surveillance of Percutaneous Transluminal Angioplasty and Wingspan Stenting for Intracranial Atherosclerotic Disease.
Imamura H, Sakai N, Sakai C, Hasegawa Y, Hyodo A, Iihara K, Minematsu K, Ogasawara K; WICAD Investigators.
World Neurosurg. 2023 May;173:e48-e54. doi: 10.1016/j.wneu.2023.01.093. Epub 2023 Jan 28.
Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis.
Alazzaz A, Thornton J, Aletich VA, Debrun GM, Ausman JI, Charbel F.
Arch Neurol. 2000 Nov;57(11):1625-30. doi: 10.1001/archneur.57.11.1625.
Therapies for Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.
Shah VA, Gonzalez LF, Suarez JI.
Neurocrit Care. 2023 Aug;39(1):36-50. doi: 10.1007/s12028-023-01747-9. Epub 2023 May 25.
Percutaneous transluminal angioplasty and stenting vs aggressive medical management on stroke or intracranial atherosclerotic stenosis: a systematic review and meta-analysis.
Lai Z, Peng M, He H, Li Y, Bai X, Cai J.
Sci Rep. 2023 May 9;13(1):7567. doi: 10.1038/s41598-023-34663-1.
Percutaneous Transluminal Angioplasty and Stenting for Progressive Intracranial Carotid Artery Stenosis Secondary to Invasive Sphenoid Sinus Aspergillosis: A Case Report.
Terada E, Nishida T, Fujita Y, Maeda Y, Hayama M, Takagaki M, Nakamura H, Oshino S, Saitoh Y, Kishima H.
NMC Case Rep J. 2023 Jul 13;10:215-220. doi: 10.2176/jns-nmc.2022-0387. eCollection 2023.
Percutaneous angioplasty and/or stenting versus aggressive medical therapy in patients with symptomatic intracranial atherosclerotic stenosis: a 1-year follow-up study.
Li X, Qin X, Liu C, Zhu L, Wang M, Jiang T, Liu Y, Li S, Shi H, Sun H, Deng Q, Zhou J.
Front Aging Neurosci. 2023 Jun 16;15:1192681. doi: 10.3389/fnagi.2023.1192681. eCollection 2023.
Successful Percutaneous Balloon Angioplasty in a Patient Presenting With STEMI and Acute Intracranial Hemorrhage.
Obagi A, Schoenfeld M.
Cureus. 2021 May 22;13(5):e15166. doi: 10.7759/cureus.15166.
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.
Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.
